Diagnostics and therapy in prostate cancer were hot topics at EANM meeting

The European Association of Nuclear Medicine returned to Barcelona in October for its annual meeting, and the UK was well represented by delegates and suppliers.

This meeting attracted good delegate numbers and was an ideal opportunity to find out about new developments, especially in tracers and therapy. According to the organisers 6,904 people from around the world participated in the conference.

EANM 2019

Prev 1 of 5 Next

Past presidents of the British Nuclear Medicine Society Professor Sobhan Vinjamuri from Liverpool and Professor Ralph McCready from Brighton join Professor Sabina Dizdarevic from Brighton and Sussex Medical School at the opening ceremony of the meeting.

European sales manager Richard Taylor with the latest preclinical PETMR from MR Solutions.

Dr Saad Alqahtani from Riyadh, Saudi Arabia, discusses the 2020 spring meeting in Liverpool with BNMS president Dr John Buscombe.

Dr Chiara Trentin and Dr Monica Enescu from Mirada Medical demonstrate the company’s nuclear medicine software.

Jeevan Virk from IEL chats with Professor Ralph McCready on the AAA stand.

Barcelona has many attractions as a conference destination, not least its accessibility, affordability and that it is warm and sunny in October.

The meeting is now predominantly a PET meeting with therapy a growing segment and scintigraphy less evident, while diagnostics and therapy for prostate cancer were the hot topics.

One thing no organiser can plan for is civil unrest and it was reported that disturbances surrounding issues of Catalan independence affected the homeward journeys of some delegates.

Lead picture: Congress chair Francesco Giammarile (left) and therapy lead and advanced practitioner in nuclear medicine physics at Maidstone and Tunbridge Wells NHS Trust Luisa Pereira (right) join the technologist prize winners at the EANM meeting for a celebratory photograph.

See this report on page 8 of the November 2019 issue of RAD Magazine.